Connection
Thomas Meyer to Patient Compliance
This is a "connection" page, showing publications Thomas Meyer has written about Patient Compliance.
|
|
Connection Strength |
|
 |
|
 |
|
0.016 |
|
|
|
-
Boxberger F, Albrecht H, Konturek PC, Reulbach U, Maennlein G, Meyer T, Hohenberger W, Hahn EG, Wein A. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial. Med Sci Monit. 2010 Feb; 16(2):CR49-55.
Score: 0.016